Decreased expression of miR-23b is associated with poor survival of endometrial cancer patients

[1]  D. Hanahan.  Hallmarks of Cancer: New Dimensions. , 2022, Cancer discovery.

[2]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[3]  D. Levine,et al.  Endometrial cancer , 2021, Nature Reviews Disease Primers.

[4]  Yuan Zhang,et al.  The Role of miR-23b in Cancer and Autoimmune Disease , 2021, Journal of oncology.

[5]  M. Masood,et al.  Endometrial carcinoma: changes to classification (WHO 2020) , 2021, Diagnostic Histopathology.

[6]  P. Włodarski,et al.  The Role of miRNAs in the Regulation of Endometrial Cancer Invasiveness and Metastasis—A Systematic Review , 2021, Cancers.

[7]  R. Płoski,et al.  Higher Mutation Burden in High Proliferation Compartments of Heterogeneous Melanoma Tumors , 2021, International journal of molecular sciences.

[8]  Minoru Kanehisa,et al.  KEGG: integrating viruses and cellular organisms , 2020, Nucleic Acids Res..

[9]  P. Włodarski,et al.  miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia—archival samples study , 2020, Histochemistry and cell biology.

[10]  L. Buchynska,et al.  Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium. , 2020, Experimental oncology.

[11]  P. Włodarski,et al.  Regulators at Every Step—How microRNAs Drive Tumor Cell Invasiveness and Metastasis , 2020, Cancers.

[12]  M. Karhanek,et al.  Discriminating miRNA Profiles between Endometrioid Well- and Poorly-Differentiated Tumours and Endometrioid and Serous Subtypes of Endometrial Cancers , 2020, International journal of molecular sciences.

[13]  Y. Tao,et al.  miRNA-based biomarkers, therapies, and resistance in Cancer , 2020, International journal of biological sciences.

[14]  P. Włodarski,et al.  miR-410-3p is induced by vemurafenib via ER stress and contributes to resistance to BRAF inhibitor in melanoma , 2020, PloS one.

[15]  G. Dittmar,et al.  Prognostic Biomarkers in Endometrial Cancer: A Systematic Review and Meta-Analysis , 2020, Journal of clinical medicine.

[16]  R. Bekkers,et al.  Diagnostic value of microRNA panel in endometrial cancer: A systematic review , 2020, Oncotarget.

[17]  Mihye Lee,et al.  Regulatory Mechanism of MicroRNA Expression in Cancer , 2020, International journal of molecular sciences.

[18]  Tao Chen,et al.  Increased estrogen levels altered microRNA expression in prostate and plasma of rats dosed with sex hormones , 2020, Andrology.

[19]  H. Bai,et al.  miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer , 2019, OncoTargets and therapy.

[20]  Minoru Kanehisa,et al.  Toward understanding the origin and evolution of cellular organisms , 2019, Protein science : a publication of the Protein Society.

[21]  P. Włodarski,et al.  Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN/AKT, and STAT3 signaling pathways , 2019, Endocrine.

[22]  H. Yassine,et al.  Expression profile of MicroRNA: An Emerging Hallmark of Cancer. , 2019, Current pharmaceutical design.

[23]  A. Tailor,et al.  The role of biomarkers in endometrial cancer and hyperplasia: a literature review , 2019, Acta oncologica.

[24]  Subbaya Subramanian,et al.  OMCD: OncomiR Cancer Database , 2018, BMC Cancer.

[25]  I. MacRae,et al.  Regulation of microRNA function in animals , 2018, Nature Reviews Molecular Cell Biology.

[26]  P. Dong,et al.  miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation , 2018, Oncotarget.

[27]  J. Gagné.  Literature Review , 2018, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[28]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[29]  Jing Li,et al.  MicroRNA-34a inhibits cells proliferation and invasion by downregulating Notch1 in endometrial cancer , 2017, Oncotarget.

[30]  Sercan Ergün,et al.  Levels of MicroRNA Heterogeneity in Cancer Biology , 2017, Molecular Diagnosis & Therapy.

[31]  Y. Song,et al.  Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer , 2017, Genes & cancer.

[32]  Z. Zong,et al.  The role of metastasis‐associated in colon cancer 1 (MACC1) in endometrial carcinoma tumorigenesis and progression , 2017, Molecular carcinogenesis.

[33]  C. Fan,et al.  Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases , 2017, Front. Immunol..

[34]  Jordan Anaya,et al.  OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs , 2016, PeerJ Comput. Sci..

[35]  P. Altevogt,et al.  Evaluating L1CAM expression in human endometrial cancer using qRT-PCR , 2016, Oncotarget.

[36]  Yong Peng,et al.  The role of MicroRNAs in human cancer , 2016, Signal Transduction and Targeted Therapy.

[37]  E. Kontomanolis,et al.  MicroRNA: The Potential Regulator of Endometrial Carcinogenesis. , 2015, MicroRNA.

[38]  Justin L. Mott,et al.  Overview of MicroRNA Biology , 2015, Seminars in Liver Disease.

[39]  Jukka Westermarck,et al.  ColonyArea: An ImageJ Plugin to Automatically Quantify Colony Formation in Clonogenic Assays , 2014, PloS one.

[40]  P. Altevogt,et al.  Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma , 2014, Oncotarget.

[41]  Hui Zhou,et al.  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..

[42]  Dongdi Wu,et al.  MicroRNA-199a-3p Regulates Endometrial Cancer Cell Proliferation by Targeting Mammalian Target of Rapamycin (mTOR) , 2013, International Journal of Gynecologic Cancer.

[43]  Steven J. M. Jones,et al.  Integrated genomic characterization of endometrial carcinoma , 2013, Nature.

[44]  D. Aoki,et al.  MicroRNAs in endometrial cancer , 2013, International Journal of Clinical Oncology.

[45]  C. Shang,et al.  MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2 , 2012, Medical science monitor : international medical journal of experimental and clinical research.

[46]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[47]  R. Klopfleisch,et al.  Excavation of a buried treasure--DNA, mRNA, miRNA and protein analysis in formalin fixed, paraffin embedded tissues. , 2011, Histology and histopathology.

[48]  Muller Fabbri,et al.  Comprehensive miRNA profiling of surgically staged endometrial cancer. , 2010, American journal of obstetrics and gynecology.

[49]  J. Paul,et al.  New Dimensions , 2011 .

[50]  Xiaoguang Fang,et al.  MicroRNAs: novel regulators in the hallmarks of human cancer. , 2009, Cancer letters.

[51]  George P Cobb,et al.  microRNAs as oncogenes and tumor suppressors. , 2007, Developmental biology.

[52]  Chang-Zheng Chen,et al.  MicroRNAs as oncogenes and tumor suppressors. , 2005, The New England journal of medicine.

[53]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[54]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[55]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[56]  J. V. Bokhman.  Two pathogenetic types of endometrial carcinoma. , 1983, Gynecologic oncology.

[57]  H. Gabra,et al.  UTERINE CANCER , 1909, British medical journal.

[58]  Supplemental Information 2: Kyoto Encyclopedia of genes and genomes. , 2022 .